Tokyo

London

New York

Register

Sign In

EUR/USD

1.1131

-0.0008

-0.07%

GBP/USD

1.2810

-0.0015

-0.12%

USD/JPY

110.96

-0.2650

-0.24%

USD/CHF

0.9789

0.0003

0.04%

EUR/GBP

0.8689

0.0004

0.05%

USD/CAD

1.3477

0.0007

0.05%

NZD/USD

0.7043

-0.0008

-0.11%

EUR/JPY

123.52

-0.3865

-0.31%

EUR/CHF

1.0897

-0.0006

-0.05%

Aevi Genomic Medicine

NASDAQ: GNMXHealthcare / Biotechnology / USA
1.18-0.02-1.67%Vol 182 8221Y Perf -77.65%
May 26th, 2017 16:00
BID1.17 ASK1.19
Open1.18 Previous Close1.20
Pre-Market- After-Trading-
 - -%  - -%
Target Price
6.90 
Analyst Rating
Moderate Buy 1.75
Potencial %
484.75 
Finscreener Ranking
—    -
Insiders Trans % 3/6/12M
100/100/100 
Value Ranking
—    -
Insiders Value % 3/6/12M
100/100/100 
Growth Ranking
—    -
Insiders Shares Cnt. % 3/6/12M
100/100/100 
Income Ranking
—    -
Market Cap (mil)45 
Earnings Rating
Price Range Ratio 52wk %
1.21 
Earnings Date

Today's Price Range

1.171.21

 

52wk Range

1.116.89

Summary:

Strong Sell

Technical Indicators: Strong Sell
Moving Averages: Strong Sell
Performance
1 Month
-12.90%
3 Months
-67.27%
6 Months
-63.68%
1 Year
-77.65%
3 Years
-
5 Years
-
Last Quotes
Name / TickerPriceChg.Chg.%
GNMX1.18-0.0200-1.67
AAPL153.61-0.2600-0.17
GOOG971.471.93000.20
MSFT69.970.35000.50
XOM81.55-0.2000-0.24
WFC52.41-0.3700-0.70
JNJ126.92-0.6100-0.48
FB152.130.17000.11
GE27.45-0.0400-0.15
JPM85.360.01000.01
...

TickerPriceChg.%52 Week High
MNK43.285.5685.83
ULTA302.403.19310.00
KSU95.953.09100.69
NVDA141.842.59145.28
COTY19.062.4730.13
CXO131.282.21147.55
NSC122.332.14125.00
CHK5.292.128.20
GPC93.282.10105.97
NEM34.112.0346.07
HBI20.701.9728.25
ORLY248.481.90292.84
GPS22.421.8230.74
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 5.40
Current Ratio 5.50
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -1 982.90
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 1.91
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -1.40
Cash Flow Per Share -0.95
Price to Tangible Book1.91
Book Value per Share0.68
Enterprise Value (in ths.)18 669
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-109.33
ROE last 12 Months -124.99
Return on Assets (5Y Avg) -68.96
ROA last 12 Months -110.12
Return on Capital (5Y Avg) -194.61
ROC last 12 Months -124.99
Return on invested Capital Q -36.35
Return on invested Capital Y-21.82
Assets Turnover-
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)-
Revenue per Share -
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q01 2017-0.27-0.29-7.41
Q04 2016-0.31-0.2229.03
Q03 2016-0.32-0.299.38
Q02 2016-0.32-0.35-9.38
Q01 2016-0.29-0.34-17.24
Q04 2015-0.27-0.257.41
Q03 2015-0.31-0.33-6.45
Q02 2015-0.34-0.2817.65
Earnings Per EndEstimateRevision %Trend
6/2017 QR-0.2635.00Positive
9/2017 QR-0.2636.59Positive
12/2017 FY-1.1018.52Positive
12/2018 FY-1.460.00-
Next Report Date10th May 2017
Estimated EPS Next Report-0.27
Estimates Count3
EPS Growth Next 5 Years %0.00
Volume Overview
Volume182 822
Shares Outstanding (in ths.)37 110
Trades Count569
Dollar Volume208 989
Avg. Volume628 329
Avg. Weekly Volume269 944
Avg. Monthly Volume391 121
Avg. Quarterly Volume869 921

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Bearish Bullish

100%0%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (50.00 %)
2 (50.00 %)
3 (100.00 %)
Moderate Buy
1 (25.00 %)
1 (25.00 %)
0 (0.00 %)
Hold
1 (25.00 %)
1 (25.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingModerate Buy
1.75
Moderate Buy
1.75
Strong Buy
1.00

There are no comments yet.

News

Plus500
x